Investments Laidlaw maintains Buy rating on IN8bio, target at $7.50 By Investing.com – Investing.com Last updated: 2024/06/15 at 11:59 PM By Editor 0 Min Read Share SHARE Laidlaw maintains Buy rating on IN8bio, target at $7.50 By Investing.com Investing.comsource You Might Also Like Explainer-How US industries deal with extreme heat By Reuters – Investing.com AI smartphone: Consumers are adopting a "wait-and-see" approach says Jefferies By Investing.com – Investing.com Prominent fund manager cuts his Nvidia stake By Investing.com – Investing.com Redrock Board Issues Statement on Forgame Holdings Limited's Defamation of HumanCode AI By Chainwire – Investing.com Nike nearer-term financial expectations now largely 'derisked' By Investing.com – Investing.com TAGGED: Articles Editor June 15, 2024 June 15, 2024 Share This Article Facebook Twitter Email Print Previous Article Barclays maintains equal weight on American Express, target $221 By Investing.com – Investing.com Next Article Audrina Miranda Joins New ‘Jurassic World’ Movie – Hollywood Reporter Leave a comment Leave a Reply Cancel reply Connect with: Your email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay Connected Facebook Like Twitter Follow Youtube Subscribe Telegram Follow - Advertisement - Latest News Newspapers Fact Sheet – Pew Research Center Business Annu Kapoor asks “Kaun hai” Kangana Ranaut? REACTS to her slap incident – Bollywood Hungama Latest News International: Top News And Analysis – CNBC Business ‘Thelma’ Director Got Blessing of Tom Cruise (and His Own Grandma) for June Squibb Action-Comedy – Hollywood Reporter Latest News